1 Research Writing and Publication (RWP), LLC, NY, USA.
2 American University of the Caribbean School of Medicine, Sint Maarten.
3 Medical University of the Americas, Nevis, West Indies.
4 Universidad Iberoamericana (UNIBE), Santo Domingo, Dominican Republic.
5 Philadelphia College of Osteopathic Medicine, Georgia, Dept. of Biomedical Sciences, USA.
6 Memorial healthcare system, Pembroke Pines FL, USA.
World Journal of Biology Pharmacy and Health Sciences, 2025, 24(02), 230-239
Article DOI: 10.30574/wjbphs.2025.24.2.0985
Received on 23 September 2025; revised on 02 November 2025; accepted on 05 November 2025
Dedifferentiated parosteal osteosarcoma (D-POS) is an isolated form of osteosarcoma in which low-grade parosteal osteosarcoma (LG-POS) progresses into a high-grade sarcoma (HGS). In this case report, the clinical, radiological, pathological, and molecular evolution of D-POS in a 24-year-old male is described. The patient initially presented with a classic LG-POS of the proximal tibia, with amplification of MDM2 and CDK4, which was treated with a wide surgical resection and no neoadjuvant or adjuvant treatment. Three years later, he developed a progressively growing large mass with severe pain, and imaging appearance of a lytic tumor, necrosis, and medullary invasion at the site of prior surgery. The LG-POS had dedifferentiated into an HGS.
The dedifferentiation of the LG-POS into high-grade sarcomatous component with severe atypia, high rate of mitosis, new mutations of TP53, and the amplification of MDM2 and CDK4 was found in histopathological examination of the recurrent mass. However, the patient died of progressive metastatic disease 2.5 years after the dedifferentiation despite the aggressive multimodal therapy, including neoadjuvant and adjuvant therapies, amputation, and pulmonary metastases metastasectomy. The case implies the highest importance of close follow-up and early detection of dedifferentiation, as well as the intricate nature of the prognosis of such aggressive variant of the tumor and necessity of developing standardized treatment plans.
Parosteal Osteosarcoma; Low-Grade; Dedifferentiation; High-Grade; Biphasic; Recurrence; Metastasis
Preview Article PDF
John Hanna, Jennifer Paz, Sandhia Senthilnathan, Elizabeth Sanchez, Phillip Pearson, Jessica Jahoda and Mohamed Aziz. Dedifferentiated Low-Grade Surface Parosteal Osteosarcoma into a High-Grade Osteosarcoma: Case Report and a Brief Review of the Literature. World Journal of Biology Pharmacy and Health Sciences, 2025, 24(02), 230-239. Article DOI: https://doi.org/10.30574/wjbphs.2025.24.2.0985.